Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
9.44M
-
Shares change
-
+1.42M
-
Total reported value, excl. options
-
$492M
-
Value change
-
+$75.9M
-
Put/Call ratio
-
1.55
-
Number of buys
-
132
-
Number of sells
-
-43
-
Price
-
$52.10
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q4 2020
211 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.44M shares
of 30.2M outstanding shares and own 31.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.98M shares), VANGUARD GROUP INC (893K shares), Invesco Ltd. (675K shares), BAKER BROS. ADVISORS LP (496K shares), STATE STREET CORP (412K shares), RAYMOND JAMES TRUST N.A. (338K shares), Russell Investments Group, Ltd. (328K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (271K shares), MORGAN STANLEY (265K shares), and Nepsis, Inc. (251K shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.